Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Published in: Osteoporosis International 2/2003

01-02-2003 | Original Article

Patient assessment using standardized bone mineral density values and a national reference database: implementing uniform thresholds for the reimbursement of osteoporosis treatments in Belgium

Authors: S. Boonen, J.-M. Kaufman, J.-Y. Reginster, J.-P. Devogelaer, on behalf of the Belgian Bone Club (BBC)

Published in: Osteoporosis International | Issue 2/2003

Login to get access

Abstract

Dual-energy X-ray absorptiometry (DXA) devices from the three main manufacturers provide different bone mineral density (BMD) values, due in part to technical differences in the algorithms for bone mineral content (BMC) and area measurements and in part to the use of different manufacturer-derived reference databases. As a result, significant differences exist between Hologic, Lunar and Norland systems in the reported young normal standard deviation scores or T-scores. In a number of European countries, including Belgium, a T-score below −2.5 is one of the key criteria for reimbursement of osteoporosis treatments. This paper addresses the first attempt to implement a nationwide, uniform expression of BMD in patients, in order to harmonize drug reimbursement. To this end, measures were taken to implement a uniform expression of BMD in Belgian patients, by converting each manufacturer's absolute BMD to standardized BMD (sBMD) values and by establishing a single national reference range.
Appendix
Available only for authorised users
Literature
1.
Looker AC, Wahner HW, Dunn WI, et al. Proximal femur bone mineral levels of US adults. Osteoporos Int 1995;5:389–409.
2.
Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 1998;8:468–489.
3.
Kanis JA, Glüer C-C for the Committee of Scientific Advisors, International Osteoporosis Foundation. An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporos Int 2000;11:192–202.
4.
Genant HK, Grampp S, Glüer CC, Faulkner KG, Jergas M, Engelke K, et al. Universal standardization for dual X-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res 1994;9:1503–1514.
5.
Hui SL, Gao S, Zhou X-H, Johnston CC, Lu Y, Glüer CC, et al. Universal standardization of bone density measurements: A method with optimal properties for calibration among several instruments. J Bone Miner Res 1997;12:1463–1470.
6.
Hanson J. Standardization of femur BMD. J Bone Miner Res 1997;12:1316–1417.
7.
Lu Y, Fuerst T, Hui S, Genant HK. Standardization of bone mineral density at femoral neck, trochanter and Ward's triangle. Osteoporos Int 2001;12:438–444.
8.
Simmons A, Simpson DE, O'Doherty MJ, Barrington S, Coakley AJ. The effects of standardization and reference values on patient classification for spine and femur dual-energy X-ray absorptiometry. Osteoporos Int 1997;7:200–206.
9.
Löfman O, Larsson L, Toss G. Bone mineral density in diagnosis of osteoporosis. J Clin Densitom 2000;3:177–186.
10.
Simmons A, Simpson DE, O'Doherty MJ, Barrington S, Coakley AJ. The effects of standardization and reference values on patient classification for spine and femur dual-energy X-ray absorptiometry. Osteoporos Int 1997;7:200–206.
11.
Pocock NA, Sambrook PN, Nguyen T, Kelly P, Freund J, Eisman JA. Assessment of spinal and femoral bone density by dual X-ray absorptiometry: comparison of Lunar and Hologic instruments. J Bone Miner Res 1992;7:1081–1084.
12.
Laskey MA, Crisp AJ, Cole TJ, Compston JE. Comparison of the effect of different reference data on Lunar DPX and Hologic QDR-1000 dual-energy X-ray absorptiometers. Br J Radiol 1992;65:1124–1129.
13.
Faulkner KG, Roberts LA, McClung MR. Discrepancies in normative data between Lunar and Hologic DXA systems. Osteoporos Int 1996;6:432–436.
14.
Valimaki MJ, Karkkainen M, Lamberg-Allardt C, et al. Exercise, smoking and calcium intake during adolescence and early adulthood as determinants of peak bone mass. BMJ 1994;309:230–235.
15.
Ahmed AIH, Blake GM, Rymer JM, Fogelman I. Screening for osteopenia and osteoporosis: do the accepted normal ranges lead to overdiagnosis? Osteoporos Int 1997;7:432–438.
16.
Gürlek A, Bayraktar M, Ariyürek M. Inappropriate reference range for peak bone mineral density in dual-energy x-ray absorptiometry: implications for the interpretation of T-scores. Osteoporos Int 2000;11: 809–813.
17.
Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. Results from the Fracture Intervention Trial (FIT). JAMA 1998;280:2077–2082.
18.
Ettinger B, Black D, Mitlack B, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. Results from a 3-year randomized clinical trial. JAMA 1999;282:637–645.
19.
Reginster J-Y, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 2000;11:83–91.
20.
Chesnut CH, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the Prevent Recurrrence of Osteoporotic Fractures (PROOF) Study. Am J Med 2000;109:267–276.
21.
WHO. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Geneva: WHO, 1994.
22.
Eddy DM, Johnston CC, Cummings SR, Dawson-Hughes B, Lindsay R, Melton LJ, et al. Osteoporosis: review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Osteoporos Int 1998;8 (Suppl. 4):S1–88.
23.
Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996;312:1254–1259.
Metadata
Title
Patient assessment using standardized bone mineral density values and a national reference database: implementing uniform thresholds for the reimbursement of osteoporosis treatments in Belgium
Authors
S. Boonen
J.-M. Kaufman
J.-Y. Reginster
J.-P. Devogelaer
on behalf of the Belgian Bone Club (BBC)
Publication date
01-02-2003
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 2/2003
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-002-1321-z

Other articles of this Issue 2/2003

Osteoporosis International 2/2003 Go to the issue

Original Article

Bone turnover markers during lactation, postpartum amenorrhea and resumption of menses

Review

Should the treatment of osteoporosis be more selective?

Original Article

Osteoporosis disease management in a rural health care population: hip fracture reduction and reduced costs in postmenopausal women after 5 years

Original Article

Increased cancellous bone in the femoral neck of patients with coxarthrosis (hip osteoarthritis): a positive remodeling imbalance favoring bone formation

Original Article

Evidence for bone formation on the external "periosteal" surface of the femoral neck: a comparison of intracapsular hip fracture cases and controls

Original Article

In a population study, can parathyroid hormone aid the definition of adequate vitamin D status? A study of people aged 65 years and over from the British National Diet and Nutrition Survey